Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nutr Res ; 32(3): 202-9, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22464807

RESUMO

Dietary products are among the therapeutic approaches used to modify intestinal microflora and to promote protective effects during the intestinal inflammatory process. Because the banana plant is rich in resistant starch, which is used by colonic microbiota for the anaerobic production of the short-chain fatty acids that serve as a major fuel source for colonocytes: first, green dwarf banana flour produces protective effects on the intestinal inflammation acting as a prebiotic and, second, combination of this dietary supplementation with prednisolone presents synergistic effects. For this, we used the trinitrobenzenesulphonic acid (TNBS) model of rat colitis. Our results revealed that the protective effect produced by a combination of 10% green dwarf banana flour with prednisolone was more pronounced than those promoted by a single administration of prednisolone or a diet containing 10% or 20% banana flour. This beneficial effect was associated with an improvement in the colonic oxidative status because the banana flour diet prevented the glutathione depletion and inhibited myeloperoxidase activity and lipid peroxidation. In addition, the intestinal anti-inflammatory activity was associated with an inhibition of alkaline phosphatase activity, a reduction in macroscopic and microscopic scores, and an extension of the lesions. In conclusion, the dietary use of the green dwarf banana flour constitutes an important dietary supplement and complementary medicine product to prevention and treatment of human inflammatory bowel disease.


Assuntos
Anti-Inflamatórios/uso terapêutico , Colite/terapia , Colo/efeitos dos fármacos , Musa/química , Fitoterapia , Prednisolona/uso terapêutico , Amido/uso terapêutico , Fosfatase Alcalina/metabolismo , Animais , Anti-Inflamatórios/farmacologia , Colite/metabolismo , Colite/patologia , Colo/metabolismo , Colo/patologia , Suplementos Nutricionais , Modelos Animais de Doenças , Sinergismo Farmacológico , Farinha , Frutas , Glutationa/metabolismo , Inflamação/metabolismo , Inflamação/patologia , Inflamação/prevenção & controle , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Oxirredução , Peroxidase/antagonistas & inibidores , Preparações de Plantas/farmacologia , Preparações de Plantas/uso terapêutico , Prebióticos , Prednisolona/farmacologia , Ratos Wistar , Amido/farmacologia , Ácido Trinitrobenzenossulfônico
2.
J Med Food ; 13(6): 1391-6, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21091252

RESUMO

Inflammatory bowel disease (IBD) is a multifactorial intestinal disorder that involves interactions among the immune system, genetic susceptibility, and environmental factors, especially the bacterial flora. Polydextrose, a polysaccharide constituted by 90% nondigestible and nonabsorbable soluble fibers, has several physiological effects consistent with those of dietary fibers, including proliferation of colon microflora. Because sulfasalazine presents serious side effects through long-term use at high doses, the aim of the present study was to evaluate the preventative effect of polydextrose on trinitrobenzenesulfonic acid-induced intestinal inflammation and its effects on the intestinal anti-inflammatory activity of sulfasalazine. Results indicated that polydextrose and its association with sulfasalazine present an anti-inflammatory effect that reduces myeloperoxidase activity, counteracts glutathione content, and promotes reductions in lesion extension and colonic weight/length ratio.


Assuntos
Fármacos Gastrointestinais/uso terapêutico , Glucanos/uso terapêutico , Doenças Inflamatórias Intestinais/prevenção & controle , Prebióticos , Fosfatase Alcalina/metabolismo , Animais , Anti-Inflamatórios não Esteroides/efeitos adversos , Anti-Inflamatórios não Esteroides/uso terapêutico , Colite/metabolismo , Colite/patologia , Colite/prevenção & controle , Colo/efeitos dos fármacos , Colo/metabolismo , Colo/patologia , Interações Medicamentosas , Glutationa/metabolismo , Doenças Inflamatórias Intestinais/metabolismo , Doenças Inflamatórias Intestinais/patologia , Masculino , Tamanho do Órgão/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Peroxidase/metabolismo , Distribuição Aleatória , Ratos , Ratos Wistar , Índice de Gravidade de Doença , Sulfassalazina/efeitos adversos , Sulfassalazina/uso terapêutico , Ácido Trinitrobenzenossulfônico/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...